Abbott Plays On Diverse Offering As It Cruises Higher Than Most In India

MUMBAI - Size matters and Abbott Laboratories amply demonstrated its significance when last year it emerged as the dark horse and acquired the India prescriptions business of Piramal Healthcare Ltd. at a steep valuation of $3.72 billion, or 9 times the sales and 31 times the pre-tax profit